Compare CASY & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CASY | IQV |
|---|---|---|
| Founded | 1959 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Diversified Commercial Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 35.1B |
| IPO Year | 1994 | 2013 |
| Metric | CASY | IQV |
|---|---|---|
| Price | $859.66 | $208.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $696.50 | $227.13 |
| AVG Volume (30 Days) | 409.3K | ★ 1.1M |
| Earning Date | 06-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ 30.87 | 4.67 |
| EPS | ★ 19.16 | 1.61 |
| Revenue | ★ $17,561,101,000.00 | $9,739,000,000.00 |
| Revenue This Year | $9.54 | $6.77 |
| Revenue Next Year | $5.34 | $5.89 |
| P/E Ratio | ★ $44.97 | $129.22 |
| Revenue Growth | 10.16 | ★ 41.60 |
| 52 Week Low | $490.00 | $154.50 |
| 52 Week High | $927.85 | $247.05 |
| Indicator | CASY | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 56.10 | 61.60 |
| Support Level | $750.64 | $206.72 |
| Resistance Level | $914.43 | $212.36 |
| Average True Range (ATR) | 28.40 | 5.45 |
| MACD | 3.59 | -0.85 |
| Stochastic Oscillator | 72.17 | 55.19 |
Casey's General Stores Inc, along with its subsidiaries, operates convenience stores mainly under the names Casey's, GoodStop (by Casey's), and Casey's General Store throughout various states in the USA, approximately half of which are located in Iowa, Missouri, and Illinois. These stores offer a broad selection of food items (which includes prepared foods such as regular and breakfast pizza, donuts, hot breakfast items, and hot and cold sandwiches), beverages, tobacco and nicotine products, groceries, health and beauty aids, automotive products, and other non-food items. The majority of the company's revenue is mainly derived from the retail sale of fuel and the products offered inside its stores.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.